The insider selling is routine in both dollar amount and proportion to market cap. No single insider sold a material stake. The cluster does not signal distress or a negative catalyst — it is consistent with normal portfolio diversification after a strong stock run. Monitor for any unexpected insider buying or a sudden increase in selling volume, but no immediate action is warranted.
Price Chart
Executive Summary
Four insiders at Spyre Therapeutics, including the CEO, CFO, and CMO, sold a total of $2.92M in open-market sales over a 7-day window ending May 8, 2026. The sales follow a Q1 earnings report showing a wider net loss of $69.0M, though the company highlighted positive Phase 2 data and a strong cash runway. The cluster value represents ~0.05% of the $6.3B market cap, which is trivial and routine for a biotech of this size.
Key Financial Metrics
Key Facts
- Four insiders sold shares totaling $2.92M in open-market transactions from May 1-8, 2026.
- CEO Turtle Cameron sold $369K, CFO Scott Burrows sold $892K, CMO Sheldon Sloan sold $1.48M, and Director Michael Henderson sold $174K.
- Total cluster value is ~0.05% of SYRE's $6.3B market cap, well below the 0.1% materiality threshold.
- Sales occurred 4 days after Q1 2026 earnings reported a net loss of $69.0M, wider than the $44.8M loss in Q1 2025.
- The company has a pro forma cash position of $1.18B following a $463M public offering, with runway into H2 2029.
- Prior 30-day insider activity included $2.9M in sells, consistent with routine insider selling patterns.
Financial Impact
Insider sales of $2.92M represent 0.05% of market cap — immaterial from a capital markets perspective.
Risk Factors
- Insider selling could accelerate if the stock continues to rally or if pipeline data disappoints.
- Wider net losses and pre-revenue status mean the stock is highly sensitive to clinical trial outcomes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1778290336581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | Insider Cluster | $88.98 $90.80 | ▼ −2.05% | ▼ −3.25% | $93.19 (−4.73%) |
Aug 11, 2026 7w ago | Insider Cluster | $102.74 $107.82 | ▼ −4.94% | ▼ −5.35% | $93.19 (+9.30%) |
Aug 6, 2026 8w ago | Insider Cluster | $103.42 $101.85 | ▲ +1.52% | ▲ +2.73% | $93.19 (+9.89%) |
Jul 3, 2026 13w ago | Insider Cluster | $86.63 $98.75 | ▲ +13.99% | ▲ +13.06% | $93.19 (+7.57%) |
Jun 27, 2026 13w ago | Insider Cluster | $90.16 $88.74 | ▲ +1.57% | ▲ +2.96% | $93.19 (−3.36%) |
Jun 26, 2026 14w ago | S-3ASR | $90.16 $88.74 | ▼ −1.57% | ▼ −2.96% | $93.19 (+3.36%) |
Jun 24, 2026 14w ago | Insider Cluster | $86.24 $88.89 | ▼ −3.07% | ▼ −1.37% | $93.19 (−8.06%) |
Jun 15, 2026 15w ago | 8-K | $83.58 $100.32 | ▲ +20.03% | ▲ +21.41% | $93.19 (+11.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $80.79 $88.34 | ▲ +9.35% | ▲ +8.67% | $93.19 (+15.35%) |
Jun 11, 2026 16w ago | Institutional Cluster | $80.77 $87.49 | ▲ +8.32% | ▲ +7.89% | $93.19 (+15.38%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access